IP Library Granted Patent US 7,807,388
Granted Patent B2
US 7,807,388 · App. 11/967,558 · Granted Oct 5, 2010

Members of the Capsaicin/Vanilloid receptor family of proteins and uses thereof

Assignee: Bayer Schering Pharma AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,807,388
App. No.
11/967,558
Granted
Oct 5, 2010
Kind
B2
Abstract

The invention provides isolated nucleic acids molecules, designated hVR-1, hVR-2, and rVR-2 nucleic acid molecules, which encode novel members of the Capsaicin/Vanilloid receptor family. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing hVR-1, hVR-2, and rVR-2 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an hVR-1, hVR-2, and rVR-2 gene has been introduced or disrupted. The invention still further provides isolated hVR-1, hVR-2, and rVR-2 proteins, fusion proteins, antigenic peptides and anti-hVR-1, anti-hVR-2, and anti-rVR-2 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

Claims (8)

1. A method for identifying a compound which modulates the activity of a polypeptide, comprising:

(a) measuring in a first cell a first rapid inactivating inward current in the absence of a test compound;

(b) measuring in a second cell a second rapid inactivating inward current in the presence of the test compound, wherein the first and second rapid inactivating inward currents are stimulated by a temperature of 48-50° C. and wherein the first and second cells express a polypeptide comprising an amino acid sequence which is at least 90% identical to the entire length of the amino acid sequence SEQ ID NO:5; and

(c) comparing the first and second rapid inactivating inward currents, wherein a difference between the first and second rapid inactivating inward currents identifies the test compound as a compound which modulates the activity of the polypeptide.

2. A method for identifying a compound which modulates the activity of a polypeptide which comprises the amino acid sequence of SEQ ID NO:5, comprising:

(a) measuring in a first cell a first rapid inactivating inward current in the absence of a test compound;

(b) measuring in a second cell a second rapid inactivating inward current in the presence of the test compound, wherein the first and second rapid inactivating inward currents are stimulated by a temperature of 48-50° C. and wherein the first and second cells express a polypeptide comprising the amino acid sequence SEQ ID NO:5; and

(c) comparing the first and second rapid inactivating inward currents, wherein a difference between the first and second rapid inactivating inward currents identifies the test compound as a compound which modulates the activity of the polypeptide.

Assignments (1)
MERGER Recorded Feb 19, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022277/0324 →
Continuity (8)
Continuation 1101309000 · Dec 15, 2004
Division 0958711100 · Jun 2, 2000
Division 0943916500 · Nov 12, 1999
Continuation In Part 0942113400 · Oct 19, 1999
Continuation In Part 0925863300 · Feb 26, 1999
Provisional Application 6010832200 · Nov 13, 1998
Provisional Application 6011407800 · Dec 28, 1998
Related Publication 20080171339A1 · Jul 17, 2008